Advanced search
Publication Cover
Expert Opinion on Orphan Drugs Volume 1, 2013 - Issue 1
Submit an article Journal homepage
2,393
Views
3
CrossRef citations to date
0
Altmetric
Reviews

Emerging drug targets in amyotrophic lateral sclerosis

Michael P BovaDepartment of Molecular Discovery, ELAN Pharmaceutical, 180 Oyster Point Boulevard, South San Francisco, CA 94080, USA+1 650 794 4284; [email protected]
, PhD (Senior Director of Target Advancement) &
Gene G KinneyDepartment of Pharmacology, ELAN Pharmaceutical, 180 Oyster Point Boulevard, South San Francisco, CA 94080, USA
, PhD (Senior Vice President)
Pages 5-20 | Published online: 17 Dec 2012

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.